Yinlong L. Zhang

Beijing, 101408, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Photothermal and immunomodulatory chitosan composite hydrogel remodels the pathological microenvironment to accelerate infected diabetic wound healing.

Photothermal and immunomodulatory chitosan composite hydrogel remodels the pathological microenvironment to accelerate infected diabetic wound healing.

Journal: Carbohydrate polymers

Published: March 16, 2026

A biomimetic Nano-platelet as an antidote for dual antiplatelet therapy-induced bleeding.

A biomimetic Nano-platelet as an antidote for dual antiplatelet therapy-induced bleeding.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: February 09, 2026

Reactive oxygen species in skin diseases: pathogenic mechanisms and nanomaterial-based therapeutic strategies.

Reactive oxygen species in skin diseases: pathogenic mechanisms and nanomaterial-based therapeutic strategies.

Journal: Frontiers in bioengineering and biotechnology

Published: January 27, 2026

Lysosome-targeted degradation of leucine-rich alpha-2 glycoprotein 1 enables chemosensitization to 5-fluorouracil in colorectal cancer.

Lysosome-targeted degradation of leucine-rich alpha-2 glycoprotein 1 enables chemosensitization to 5-fluorouracil in colorectal cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 10, 2026

Counterion-Engineered Water-Stable Intravenously Administered Nanoparticles Enable In Vivo Reversal of Ticagrelor.

Counterion-Engineered Water-Stable Intravenously Administered Nanoparticles Enable In Vivo Reversal of Ticagrelor.

Journal: Angewandte Chemie (International ed. in English)

Published: October 24, 2025

Ionizable Nano-PROTAC Overcomes Endosomal Entrapment for Enhanced LRG1 Degradation and Tumor Suppression.

Ionizable Nano-PROTAC Overcomes Endosomal Entrapment for Enhanced LRG1 Degradation and Tumor Suppression.

Journal: Angewandte Chemie (International ed. in English)

Published: September 15, 2025

Mesoporous Silica Nanotraps for Mitigating Bleeding Risk From 'Irreversible' Antiplatelet Drugs.

Mesoporous Silica Nanotraps for Mitigating Bleeding Risk From 'Irreversible' Antiplatelet Drugs.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: January 22, 2025

Clickable liposomes for on-demand reversal of antiplatelet drugs: Towards a safe management of bleeding risks associated with antithrombotic therapy.

Clickable liposomes for on-demand reversal of antiplatelet drugs: Towards a safe management of bleeding risks associated with antithrombotic therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 31, 2024

Cationic liposomes as broad-spectrum antidotes for heparin-based anticoagulants.

Cationic liposomes as broad-spectrum antidotes for heparin-based anticoagulants.

Journal: Acta biomaterialia

Published: October 25, 2024

Engineered P2Y12-Overexpressing Cell-Membrane-Wrapped Nanoparticles for the Functional Reversal of Ticagrelor and Clopidogrel.

Engineered P2Y12-Overexpressing Cell-Membrane-Wrapped Nanoparticles for the Functional Reversal of Ticagrelor and Clopidogrel.

Journal: Nano letters

Published: August 14, 2024

Correction: Anti-lymphangiogenesis for boosting drug accumulation in tumors.

Correction: Anti-lymphangiogenesis for boosting drug accumulation in tumors.

Journal: Signal transduction and targeted therapy

Published: June 08, 2024

Enteric-coated cerium dioxide nanoparticles for effective inflammatory bowel disease treatment by regulating the redox balance and gut microbiome.

Enteric-coated cerium dioxide nanoparticles for effective inflammatory bowel disease treatment by regulating the redox balance and gut microbiome.

Journal: Biomaterials

Published: May 21, 2024

Showing 1-12 of 83

Last Updated: 09/26/2026